VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV · IEX Real-Time Price · USD
0.599
+0.009 (1.59%)
At close: Apr 25, 2024, 4:00 PM
0.618
+0.018 (3.02%)
Pre-market: Apr 26, 2024, 4:40 AM EDT
VBI Vaccines Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for VBI Vaccines.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for VBI Vaccines.
Recommendation Trends
| Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $60 → $6 | Buy | Maintains | $60 → $6 | +901.00% | Apr 13, 2023 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $150 → $60 | Strong Buy → Buy | Downgrades | $150 → $60 | +9,910.01% | Nov 11, 2022 |
| Raymond James | Raymond James | Strong Buy Maintains $180 → $150 | Strong Buy | Maintains | $180 → $150 | +24,925.03% | Aug 9, 2022 |
| Raymond James | Raymond James | Strong Buy Maintains $270 → $180 | Strong Buy | Maintains | $270 → $180 | +29,930.03% | Mar 8, 2022 |
| BMO Capital | BMO Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 27, 2018 |
Financial Forecast
Revenue This Year
20.24M
from 8.68M
Increased by 133.10%
Revenue Next Year
32.02M
from 20.24M
Increased by 58.23%
EPS This Year
-0.84
from -6.03
EPS Next Year
-2.43
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 20.8M | 33.0M |
| Avg | 20.2M | 32.0M |
| Low | 19.4M | 30.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 140.0% | 62.9% |
| Avg | 133.1% | 58.2% |
| Low | 124.0% | 52.0% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.86 | -2.50 |
| Avg | -0.84 | -2.43 |
| Low | -0.80 | -2.33 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.